STVN - Stevanato Group S.p.A. Stock Analysis

Stock Taper

SCREENER COMPARE ANY 2 STOCKS

STVN

STEVANATO GROUP S.P.A.

NYSE

$21.03

▼ DOWN 5.70% (-1.27)

KEY STATISTICS

Market Cap$5.74 B

52w High$28.00

52w Low$12.89

Dividend Yield0.36%

FrequencyAnnual

P/E31.86

Volume344.02K

Shares Out.273.01M

COMPANY

LEADERSHIP

CHIEF EXECUTIVE

Franco Stevanato

ABOUT

SECTOR

Healthcare

WENT PUBLIC

July 16, 2021

METHOD OF GOING PUBLIC

IPO

FULL TIME EMPLOYEES

6,010

PRICE TARGET

Target High$32.00

Target Low$32.00

Target Median$32.00

Target Consensus$32.00

UPCOMING EARNINGS

DateNov 5, 2026

DayThursday

Rev. Est.$374.49M

NOV

THU

PRICE

$21.03 ▼ DOWN 5.70% (−$1.27)

About Stevanato Group S.p.A.

https://www.stevanatogroup.com ↗

Stevanato Group S.p.A., founded in 1949 and based in Italy, designs and manufactures integrated pharma and healthcare solutions, including containment, drug delivery, medical devices, diagnostics, and packaging machinery.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT STEVANATO GROUP S.P.A. IS KNOWN FOR

Vertiva™ on-body delivery system

Stevanato Group's wearable device enables in-home, subcutaneous drug delivery with a reusable controller and pre-filled pod, offering an innovative, patient-centric solution for various therapies in the biologics market.

COMPETITORS

COMPETITOR

Revenue by Geography

REGION	FY2022	FY2023	FY2024	FY2025
Europe Middle East and Africa	$599.71M	$634.05M ▲	$667.83M ▲	$690.34M ▲
North America	$250.84M	$317.54M ▲	$308.95M ▼	$362.06M ▲
Asia Pacific	$100.26M	$102.9M ▲	$96.23M ▼	$101.48M ▲
ITALY	—	—	—	$93.33M
South America	$32.87M	$30.87M ▼	$31.02M ▲	$32.4M ▲